| Product Name | MF | CAS | Details |
|---|
| Desoximetasone Impurity 17 | C29H34FNaO9S | 3936-02-5 | Details |
| Dexamethasone Impurity G | C24H31FO5 | 1597-78-0 | Details |
| Desoximetasone Impurity E | C24H33FO6 | 1524-94-3 | Details |
| Desoximetasone Impurity | C36H53FN4O6S | 85679-56-7 | Details |
| Desoximetasone Impurity C | Details |
| Desoximetasone Impurity B | Details |
| Desoximetasone Impurity | C22H27FO6 | 473273-04-0 | Details |
| Desoximetasone Impurity | C7H8Cl2N6 | 82778-08-3 | Details |
| Desmethyl Erlotinib Carboxylate Acid | C21H19N3O5 | 1170354-84-3 | Details |
| Darunavir-O-Glucuronide | C33H45N3O13S | 1159613-27-0 | Details |
| D-Darunavir | C27H37N3O7S | 1399859-60-9 | Details |
| Darunavir Impurity 9 | C7H10O4 | 866594-61-8 | Details |
| Darunavir-d9 | C27H37N3O7S | 1133378-37-6 | Details |
| Darunavir-N-Glucuronide | C33H45N3O13S | 1159613-25-8 | Details |
| Erlotinib Impurity 11 | C16H23N3O4 | 950596-59-5 | Details |
| Erlotinib Impurity 11 | C21H19N3O5 | 882172-60-3 | Details |
| Erlotinib Impurity 1 | C22H24ClN3O4 | 2204518-92-1 | Details |
| Erlotinib Impurity 29 | C13H19NO6 | 574738-66-2 | Details |
| Erlotinib Impurity 1 | C22H23N3O5 | 882420-22-6 | Details |
| Febuxostat Impurity 27;3-cyano-4-isobutoxybenzamide | Details |
| Febuxostat Impurity 32;2-(4-hydroxy-3-((hydroxyimino)methyl)phenyl)-4-methylthiazole-5-carboxylic acid | C12H12N2O | 1805770-41-5 | Details |
| Febuxostat Impurity 30;(Z)-ethyl 2-(3-((hydroxyimino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate | Details |
| Febuxostat Impurity 26;3-cyano-4-isobutoxybenzoic acid | C14H12N2O3S | 1886961-39-2 | Details |
| Febuxostat Impurity 31;diethyl 2,2'-(4-hydroxy-5-(hydroxymethyl)-1,3-phenylene)bis(4-methylthiazole-5-carboxylate) | Details |
| Febuxostat Impurity 36;2-(3-cyano-4-ethoxyphenyl)-4-methylthiazole-5-carboxylic acid | C12H12N2O | 1805770-40-4 | Details |
| Erlotinib O-Desmethyl Metabolite Isomer (M13) HCl | C21H22ClN3O4 | 183365-34-6 | Details |
| Erlotinib O-Desmethyl Metabolite Isomer (M13) | C21H21N3O4 | 183320-29-8 | Details |
| 3, 4-dihydroxybenzaldehyde | C7H6O3 | 139-85-5 | Details |
| Erlotinib Impurity 71 | C24H25N3O5 | 2055840-54-3 | Details |
| Febuxostat Impurity 47;2-(2-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid | C18H21NO4S | Details |
| Valsartan Methyl Ester | C18H20N2O3S | 2375033-35-3 | Details |
| Febuxostat Impurity 40;4-hydroxybenzonitrile | Details |
| Febuxostat Impurity 42 | C12H14O5 | 100118-38-5 | Details |
| Febuxostat Impurity 50;ethyl 2-(4-hydroxy-3-((hydroxyimino)methyl)phenyl)-4-methylthiazole-5-carboxylate | C17H18N2O3S | 144060-84-4 | Details |
| Febuxostat Impurity 49;ethyl 2-(3,5-diformyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate | Details |
| Febuxostat Impurity 53;isobutyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate | C24H28N2O5S2 | 1346238-13-8 | Details |
| Febuxostat Impurity 30 | C18H22N2O4S | 1271738-74-9 | Details |
| Febuxostat Impurity 106 | C18H22N2O4S | 1346238-15-0 | Details |
| Febuxostat Impurity 45 | C11H10N2O | 1229019-33-3 | Details |
| Febuxostat Impurity 46 | C12H13NO3 | 528607-60-5 | Details |
| Febuxostat Impurity 47 | C12H14N2O2 | 161718-85-0 | Details |
| Febuxostat Impurity 52 | C11H14O2 | 18962-07-7 | Details |
| Febuxostat Impurity 46 | C13H13NO3S | 118485-48-6 | Details |
| Febuxostat Impurity 43;4-hydroxyisophthalonitrile | Details |
| Febuxostat Impurity 41;4-hydroxybenzothioamide | C19H19N3O3S | Details |
| Febuxostat Impurity 44;ethyl 2-(3-formyl-2-hydroxyphenyl)-4-methylthiazole-5-carboxylate | C17H18N2O3S | Details |
| Ezetimibe Impurity Q1;(S)-3-((2R,5R)-5-(4-fluorophenyl)-5-hydroxy-2-((S)-hydroxy(4-hydroxyphenyl)methyl)pentanoyl)-4-phenyloxazolidin-2-one | C27H26FNO6 | Details |
| Ezetimibe Impurity Q2;(S)-3-((2R,5R)-5-(4-fluorophenyl)-5-hydroxy-2-((R)-hydroxy(4-hydroxyphenyl)methyl)pentanoyl)-4-phenyloxazolidin-2-one | C27H28FNO6 | Details |
| Febuxostat Impurity 37 | C18H20N2O3S | 2230270-05-8 | Details |
| Febuxostat Impurity 82 | C18H21NO4S | 2230270-03-6 | Details |
| Erlotinib Impurity 26 | C9H10O4 | 3943-89-3 | Details |
| Erlotinib Impurity | C21H22ClN3O4 | 183320-51-6 | Details |
| Erlotinib Impurity 35 | C13H17N3O4 | 1839513-98-2 | Details |
| D-Fudosteine | C6H13NO3S | 1023971-10-9 | Details |
| Didesmethyl Erlotinib | C20H19N3O4 | 183321-84-8 | Details |
| DNV-II impurity 2 | C25H35N3O7S | 1133153-38-4 | Details |
| Erlotinib Impurity 39 | Details |
| Erlotinib Impurity 45 | C21H20ClN3O3 | 183321-83-7 | Details |
| Desoximetasone Impurity | C20H25FO3 | 2285-53-2 | Details |
| Cilnidipine Impurity 27 | C21H28O2 | 152-62-5 | Details |
| Rosuvastatin EP Impurity A | C21H28O2 | 25093-47-4 | Details |
| Erlotinib impurity 70 | C13H19NO5 | 1494468-76-6 | Details |
| Erlotinib Impurity 68 | C20H17Cl2N3O2 | 183321-82-6 | Details |
| Erlotinib Impurity 66 | C13H17NO7 | 1384975-87-4 | Details |
| Erlotinib Impurity 46 | C16H11N3O2 | 938185-06-9 | Details |
| DNV-II impurity 1 | C25H35N3O7S | 1005324-46-8 | Details |
| DL-Folic Acid | C19H19N7O6 | 65165-92-6 | Details |
| D-Folic Acid | C19H19N7O6 | 65165-91-5 | Details |
| Darunavir Impurity 7 (S,S-Isomer) | C20H29N3O3S | 192800-79-6 | Details |
| Desoximetasone Impurity 16 | C28H32FNO6 | 2265-64-7 | Details |
| Tacrolimus EP Impurity E | C44H71NO12 | 104987-30-6 | Details |
| Erlotinib-d6 HCl | C22H18ClD6N3O4 | 1189953-78-3 | Details |
| Esomeprazole Impurity 25;2-(((3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-6-methoxy-1H-benzo[d]imidazole | C8H8N2O3S | 1080689-87-7 | Details |
| erythro-Hydroxy Bupropion HCl | C13H21Cl2NO | 80478-43-9 | Details |
| Pitavastatin Impurity 54 | C50H50CaN2O8 | 1258947-30-6 | Details |
| Tacrolimus Diene | C43H67NO12 | 132172-14-6 | Details |
| Febuxostat Impurity 52 | C16H16N2O4S | Details |
| Febuxostat Impurity 88 | C11H9NO3S | 886501-78-6 | Details |
| (R)-Amlodipine | C18H21NO5S | 2095166-41-7 | Details |
| Erlotinib Hydrochloride iMpurity 18 | Details |
| Erlotinib Impurity 67 | C21H20ClN3O3 | 183321-85-9 | Details |
| Erlotinib Hydrochloride iMpurity 14 | Details |
| Febuxostat iMpurity 20 | Details |
| Noradrenaline Impurity 26 | C22H23N3O4 | 68304-21-3 | Details |
| Esomeprazole Impurity 22 | C9H12ClNO2S | Details |
| Esomeprazole Impurity 24 | Details |
| Esomeprazole Impurity 23 | C17H19N3O3S2 | Details |
| Erlotinib Hydrochloride iMpurity 15 | Details |
| Dexamethasone Sodium Phosphate EP Impurity H | C22H30FO8P-2 | 162968-22-1 | Details |
| (R)-Amlodipine | C24H30O6 | 2884-51-7 | Details |
| 4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl) | Details |
| Erlotinib iMpurity 40 | C8H7N | Details |
| Ezetimibe Impurity M | C20H21NO4 | Details |
| Ezetimibe Impurity R | C27H24FNO5 | Details |
| Erlotinib iMpurity 41 | C8H7N | 14235-81-5 | Details |
| Captopril Impurity 1 | C9H15NO3S | 119238-52-7 | Details |
| Darunavir Impurity A | C20H29N3O3S | 169280-56-2 | Details |
| (8S,9R,10S,11S,13S,14S,16R,17S) | C22H29FO4 | 382-67-2 | Details |
| (4aS,4bS,5aS,6aS,7R,8R,9aS,9bS) | C22H28O5 | 24916-90-3 | Details |
| Erlotinib Impurity 30 | C15H22O6 | 183322-16-9 | Details |
| Product Total： Product Page： | ||||
| 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 | ||||